Stock Earnings

Question 1

What are Panacos Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Panacos Pharmaceuticals Inc has a total asset of $55, Net loss of $-37

Question 2

What are the key financial ratios for PANC?

Accepted Answer

Panacos Pharmaceuticals Inc's Current ratio is 2.11, has a Net margin is 0, sales per share of $0.

Question 3

How is Panacos Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Panacos Pharmaceuticals Inc data is not available.

Question 4

Is Panacos Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, Panacos Pharmaceuticals Inc has a net loss of $-37

Question 5

Does Panacos Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Panacos Pharmaceuticals Inc has liability of 26

Question 6

How many outstanding shares for Panacos Pharmaceuticals Inc?

Accepted Answer

Panacos Pharmaceuticals Inc has a total outstanding shares of 53.54

Breakdown	TTM	12/31/2007	12/31/2006	12/31/2005	12/31/2004	12/27/2003
Revenue	0	0	0	1	1	1
Revenue Growth (YoY)	--	--	-100%	0%	0%	-75%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	11	12	17	8	2	0
Research & Development	23	25	24	19	11	4
Operating Expenses	34	37	41	27	13	5
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-35	-37	-38	-59	-12	-4
Income Tax Expense	0	0	0	0	0	0
Net Income	-35	-37	-38	-59	-13	-5
Net Income Growth	-3%	-3%	-36%	354%	160%	-75%
Shares Outstanding (Diluted)	53.64	53.14	50.52	34.42	0.96	0.4
Shares Change (YoY)	0%	5%	47%	3,478%	139%	25%
EPS (Diluted)	-0.66	-0.7	-0.75	-1.71	-14.51	-13
EPS Growth	-4%	-7%	-56%	-88%	12%	-79%
Free Cash Flow	-31	-31	-30	-21	-9	-3
Free Cash Flow Per Share	-0.57	-0.58	-0.59	-0.61	-9.35	-7.44
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	-2,600%	-1,100%	-400%
Profit Margin	0%	0%	0%	-5,900%	-1,300%	-500%
Free Cash Flow Margin	0%	0%	0%	-2,100%	-900%	-300%
EBITDA	-34	-37	-41	-26	-11	-4
EBITDA Margin	0%	0%	0%	-2,600%	-1,100%	-400%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-34	-37	-41	-26	-11	-4
EBIT Margin	0%	0%	0%	-2,600%	-1,100%	-400%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Panacos Pharmaceuticals Inc (PANC) Price